Clinical Trials Browser

Phase 1/2 × Carcinoma, Non-Small-Cell Lung × Receptor Protein-Tyrosine Kinases × Clear all

NCT00673777 2008-05-14

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung